Maxiom Group and Lupin Pharmaceuticals, Inc. Act to Ensure Safety of U.S. Drug Supply

WALTHAM, Mass.--(BUSINESS WIRE)--Maxiom Consulting Group, Inc., a leading strategic business and IT consulting firm exclusively serving the life sciences industry, today announced that it has partnered with Lupin Pharmaceuticals, Inc. in the development of a Serialization and Pedigree Readiness Plan to help ensure the safety and security of their U.S. drug supply. Lupin is a leading global player in Anti-TB, Cephalosporins (anti-infectives), and Cardiovascular drugs (prils and statins) and has a notable presence in the areas of diabetology, NSAIDs, and Asthma.